STAB Stock - Statera Biopharma, Inc.
Unlock GoAI Insights for STAB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-488,314 | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-98,343,803 | $-10,501,668 | $-2,814,176 | $-4,799,906 | $-5,600,810 |
| Net Income | $-174,408,164 | $-13,224,554 | $-3,348,255 | $-3,611,973 | $-9,706,456 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-4.97 | $-0.52 | $-0.13 | $-0.32 | $-0.87 |
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.
Visit WebsiteEarnings History & Surprises
STABEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 14, 2024 | — | — | — | — |
Q2 2024 | May 17, 2024 | — | — | — | — |
Q1 2024 | Feb 12, 2024 | — | — | — | — |
Q3 2023 | Sep 8, 2023 | — | — | — | — |
Q3 2023 | Aug 29, 2023 | — | — | — | — |
Q2 2023 | May 29, 2023 | — | — | — | — |
Q1 2023 | Feb 13, 2023 | — | — | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.07 | — | — |
Q4 2022 | Oct 28, 2022 | — | $-0.08 | — | — |
Q4 2022 | Oct 21, 2022 | — | $-0.23 | — | — |
Q4 2022 | Oct 5, 2022 | — | $-2.20 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.47 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.26 | — | — |
Q2 2021 | May 14, 2021 | — | $-0.21 | — | — |
Q1 2021 | Mar 22, 2021 | — | $-0.16 | — | — |
Q4 2020 | Nov 16, 2020 | — | $-0.22 | — | — |
Q3 2020 | Aug 14, 2020 | — | $-0.01 | — | — |
Q2 2020 | May 15, 2020 | — | $-0.03 | — | — |
Q4 2019 | Nov 14, 2019 | — | $-0.04 | — | — |
Q3 2019 | Aug 14, 2019 | — | $-0.05 | — | — |
Latest News
Frequently Asked Questions about STAB
What is STAB's current stock price?
What is the analyst price target for STAB?
What sector is Statera Biopharma, Inc. in?
What is STAB's market cap?
Does STAB pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to STAB for comparison